Cancer cachexia is associated with the IL10 -1082 gene promoter polymorphism in patients with gastroesophageal malignancy

American Journal of Clinical Nutrition

Volumn 89, Issue 4, 2009, Pages 1164-1172

  Deans, D A Chris ^a   Tan, Benjamin H L ^a   Ross, James A ^a   Rose Zerilli, Matthew ^b   Wigmore, Stephen J ^a   Howell, W Martin ^c   Grimble, Robert F ^b   Fearon, Kenneth C H ^a,d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; AGED; ALLELE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD LEVEL; BODY MASS; CACHEXIA; CANCER CACHEXIA; CONCENTRATION (PARAMETERS); CYTOKINE PRODUCTION; CYTOMETRY; DIETARY INTAKE; DYSPHAGIA; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; WEIGHT REDUCTION; BLOOD; ESOPHAGUS TUMOR; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; STOMACH TUMOR;

AGED; C-REACTIVE PROTEIN; CACHEXIA; CYTOKINES; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS;

EID: 63649089132     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2008.27025     Document Type: Article

References (35)

1. Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with non-operable non-small-cell lung cancer. Br J Cancer 2003;89:1028-30.
2. Kodama J, Miyagi Y, Seki N, et al. Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1999;82:107-10.
3. Nozoe T, Saeki H, Sugimachi K. Significance of preoperative elevation of CRP as an indicator of prognosis in oesophageal carcinoma. Am J Surg 2001;182:197-201.
4. Falconer JS, Fearon KCH, Ross JA, et al. Acute phase protein response and survival duration of patients with pancreatic cancer. Cancer 1995; 75:2077-82.
5. Wigmore SJ, Fearon KCH, Lai PBS, et al. Recombinant and tumour-cell derived IL-8 stimulates acute phase protein production by isolated human hepatocytes. Am J Physiol 1997;273:E720-6.
6. O'Gorman P, McMillan DC, McArdle CS. Longitudinal study of weight, appetite, performance status and inflammation in advanced gastrointestinal cancer. Nutr Cancer 1999;35:127-30.
7. Falconer JS, Fearon KCH, Plester CE, Ross JA, Carter DC. Cytokines, the acute phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 1994;219:325-31.
8. Argiles JM, Alvarez B, Lopez-Soriano FJ. The metabolic basis of cancer cachexia. Med Res Rev 1997;17:477-98.
9. Gelin J, Moldawer LL, Lonnroth C, et al. Role of endogenous TNF α and IL-1 for experimental tumour growth and the development of cancer cachexia. Cancer Res 1991;51:415-21.
10. Strassmann G, Fong M, Kenney JS, Jacob CO. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992;89:1681-4.
11. Tagore A, Gonsalkorale WM, Pravica V, et al. Interleukin-10 genotypes in inflammatory bowel disease. Tissue Antigens 1999;54:386-90.
12. Burzotta F, Iacoviello L, Di Castelnuovo A, et al. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalisation after surgical coronary revascularisation. Am J Cardiol 2001;88:1125-8.
13. Barber MD, Powell JJ, Lynch SF, Fearon KCH, Ross JA. A polymorphism of the interleukin-1 β gene influences survival in pancreatic cancer. Br J Cancer 2000;83:1443-7.
14. Deans C, Rose-Zerilli M, Wigmore S, et al. Host cytokine genotype is related to adverse prognosis and systemic inflammation in gastro- oesophageal cancer. Ann Surg Oncol 2007;14:329-39.
15. Martignoni ME, Kunze P, Hildebrandt W, et al. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia. Clin Cancer Res 2005;11:5802-8.
16. Deans DAC, Wigmore SJ, Gilmour H, Paterson-Brown S, Ross JA, Fearon KCH. Tumour tissue interleukin-1 β is associated with systemic inflammation-a marker of reduced survival in gastro-oesophageal cancer. Br J Cancer 2006;95:1568-75.
17. Zhang D, Zheng H, Zhou Y, Tang X, Yu B, Li J. Association of IL-1beta gene polymorphism with cachexia from locally advanced gastric cancer. BMC Cancer 2007;7:45.
18. Jatoi A, Nguyen PL, Foster N, et al. Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma. J Support Oncol 2007;5:41-6.
19. Broekhuizen R, Grimble RF, Howell WM, et al. Pulmonary cachexia, systemic inflammatory profile, and the interleukin-1beta -511 single nucleotide polymorphism. Am J Clin Nutr 2005;82:1059-64.
20. Goyenechea E, Dolores PM, Alfredo Martinez J. Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-gamma2 gene polymorphisms. Br J Nutr 2006;96:965-72.
21. Jelliffe DB. The assessment of nutritional status of the community. WHO Monograph 53. Geneva, Switzerland: World Health Organization, 1966.
22. Bishop CW, Bowen PE, Ritchey SJ. Norms for nutritional assessment of American adults by upper arm anthropometry. Am J Clin Nutr 1981;34: 2530-9.
23. Department of Health. Dietary reference values for food, energy and nutrients for the United Kingdom. 41. London, United Kingdom: HMSO, 1991.
24. Knyrim K, Wagner H, Bethge N, Keymling M, Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993;329:1302-7.
25. Gabay C, Kushner I. Acute phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
26. Wigmore SJ, Fearon KCH, Sangster K, Maingay JP, Garden OJ, Ross JA. Cytokine regulation of constitutive production of IL-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer. Int J Oncol 2002;21:881-6.
27. Schaaf BM, Boehmke F, Esnaashari H, et al. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med 2003;168:476-80.
28. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003;104:617-23.
29. Hillyer L, Dao B, Niemiec P, et al. Elevated bioactivity of the tolero- genic cytokines, interleukin-10 and transforming growth factor-beta, in the blood of acutely malnourished weanling mice. Exp Biol Med (Maywood) 2006;231:1439-17.
30. Manigrasso MR, Ferroni P, Santilli F, et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. J Clin Endocrinol Metab 2005;90:5876-9.
31. Ebrahimi B, Tucker SL, Li D, Abbruzzesse JL, Kurxrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 2004;101:2727-36.
32. Tanaka F, Tominaga K, Shiota M, et al. Interleukin-10 gene transfer to peritoneal mesothelial cells suppresses peritoneal dissemination of gastric cancer cells due to a persistently high concentration in the peritoneal cavity. Cancer Gene Ther 2008;15:51-9.
33. Kundu N, Beaty TL, Jackson MJ, Fulton AM. Antimetastatic and an- titumor activities of interleukin 10 in a murine model of breast cancer. J Natl Cancer Inst 1996;88:536-41.
34. Zheng LM, Ojcius DM, Garaud F, et al. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J Exp Med 1996; 184:579-84.
35. Howell WM, Rose-Zerilli MJ. Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J Nutr 2007;137:194S-9S.